Doppelgerz® V.I.P. Complex for beauty and health

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.001092.03.17
Date of registration and renewal:06.03.2017
Dosage form: & nbspTablets weighing 1850 mg.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of multivitamins containing individual minerals and mineral complexes BAD-sources of vitamin-mineral complexes Supplements containing zinc, copper, manganese Supplements containing calcium and phosphorus Supplements containing selenium Supplements containing potassium and magnesium
Composition: & nbspBeta-carotene powder (provitamin A), biotin, folic acid, thiamine nitrate (vitamin B1), riboflavin (vitamin B2), pyridoxine (vitamin B6), cyanocobalamin (vitamin B12), cholecalciferol (vitamin D3), ascorbic acid (vitamin C) ), DL-alpha-tocopheryl acetate, sodium selenate, magnesium oxide, zinc citrate, amorphous silica, calcium carbonate.
Excipients: croscarmellose sodium, MCC, silicon oxide, magnesium stearate, shellac solution, hypromellose, talc, olive oil natural, iron oxide red, titanium dioxide.
Scope: & nbspTo realize the population as a biologically active food additive - an additional source of beta-carotene, biotin, folic acid, vitamins B1, B2, B6, B12, D3, C, E, selenium, magnesium, zinc, calcium.
Suggested Usage: & nbspAdults take 1 tablet 1 time per day with meals. Duration of admission is 1 month.
Contraindications:Individual intolerance to food components, pregnant and lactating women.
Special instructions:Before use, consult a physician.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children at a temperature not exceeding + 25 ° С.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.006162.05.14 dated May 27, 2014, the expert opinion of the Federal State Unitary Enterprise ФЦЗ ФЦГ and Э Роспотребнадзора №10-2 ФЦ / 347 from 28.01.09, FGBU Research Institute of Nutrition RAMS № 72 / E-375 / b-14 of 10/04/2014.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp19.03.2017
Instructions
Up